CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC
Clinical trial NCT04739358 · TERMINATED
Trial details
- NCT number
- NCT04739358
- Sponsor
- Criterium, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2023-06-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.